Market Tracker

02/20 8:22am ET

Dynavax Technologies Corp (NASDAQ:DVAX)

17.23
Delayed Data
As of Feb 16
 +0.175 / +1.03%
Today’s Change
3.90
Today|||52-Week Range
24.45
-7.89%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close17.05
Today’s open17.15
Day’s range17.05 - 17.40
Volume714,117
Average volume (3 months)1,592,239
Market cap$1.0B
Data as of 3:59pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+10.15%
Earnings growth (this year)+41.23%
Earnings growth (next 5 years)--
Revenue growth (last year)+172.67%
P/E ratioNM
Price/Sales13.77
Price/Book7.45

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA+0.29+0.90%
XNCRXencor Inc+0.75+3.04%
DERMDermira Inc-0.76-2.69%
AIMTAimmune Therapeutics...-1.04-2.72%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 12, 2018
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$11.0M
Annual profit (last year)-$112.4M
Net profit margin-1,018.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts